”) reported consolidated revenues of Baht 426.1 million, a decrease of 13.7% compared to the same quarter last year. Sales revenues reported at Baht 415.3 million, declined by 16% due to slower sales in
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Company”) reported consolidated revenues of Baht 493.5 million, decreased by 1.1% compared to the same quarter last year. Total sale was Baht 495.2 million, decreased by 0.1%. The contributions were from
-Translated Version- No. ECF2 032/2020 14 August 2020 Subject: Management Discussion and Analysis of the 2nd quarter and 6-month period ended 30 June 2020 To President The Stock Exchange of Thailand
Governance Project" of the Securities and Exchange Commission (SEC). An English version of the MD&A has been prepared from the Thai version. In the event of a conflict or a difference in interpretation between
Exchange of Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.4/2020, held on August 14, 2020, has approved the financial statements of the
assistance of a subsidiary To: The President The Stock Exchange of Thailand GFPT Public Company Limited (“The Company” or “GFPT”), held the Board of Directors’ meeting no. 7/2560 on August 25th, 2017, approved
Page 1 RJH – SET 14/2019 13 August 2019 Subject : Notification of Asset Acquisition and Connected Transaction To : The President The Stock Exchange of Thailand Attachment : Information memorandum on
The Stock Exchange of Thailand The Board of Director of Eason & Co Public Company Limited (“Company”) meeting No. 3/2020 dated on May 13, 2020 passed the resolution to extend financial assistance period